Gama Paul sold $698K of PG

Gama Paul (CEO- Health Care) sold 4,331 shares of PROCTER & GAMBLE Co (PG) at $161.27 ($0.70M total) on 2026-10-23.

Original reporting
SEC EDGAR · Gama Paul
Published Oct 26, 2026, 2:01 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 26, 2026, 2:06 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$PG
Bearish
medium confidence
Mentioned
$PG
Relevance
5/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$PGBearishLow
01

Why it matters

The disclosed sale is modest and unlikely to move the stock significantly, but it provides a data point for monitoring insider activity.

02

Market read

A small insider sale by a senior executive, low immediate market impact.

03

What to watch

The sale size is tiny relative to PG's market cap and may not reflect company fundamentals.

Relevance 5/10Novelty 4/10Timing: filed today

Background

Form 4 filings disclose insider transactions and are used by traders to gauge potential sentiment shifts.

Company-level read

Ticker impact

$PGBearishMedium confidence
Context

CEO Gama Paul sold 4,331 shares of Procter & Gamble for $698,460, reducing his stake to 46,793 shares.

Expected impact

likely modest downward pressure as the market prices the insider sale

Evidence & confidence

A $698k sale by a senior executive is a primary filing but the amount is small relative to market cap, so impact is limited.

Market effects

Minimal effect on consumer staples sector; insider sales are routine.

No regional impact.

Low relevance globally.

Counterpoint

The sale could be interpreted as a routine portfolio rebalancing, not a negative signal.

Key entities

  • Procter & Gamble Co

    Consumer goods conglomerate (ticker PG).

  • Gama Paul

    CEO of Health Care division at Procter & Gamble.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$PGMedAI 9/10

The Procter & Gamble Company closed an underwritten public offering of €750,000,000 aggregate principal amount of 3.750% Notes due November 3, 2030…

PROCTER & GAMBLE Co (PG) filed an SEC Form 8-K — Other Events. Item 8.01 Other Events. On November 3, 2026, The Procter & Gamble Company (the “Company”) closed an underwritten public offering of €750,000,000 aggregate principal amount of 3.750% Notes due November 3, 2030, €1,000,000,000 aggregate principal amount of 4.100% Notes due November

$PGMedAI 9/10

The Procter & Gamble Company closed an underwritten public offering of $750,000,000 aggregate principal amount of 5.125% Notes due October 30, 2031…

PROCTER & GAMBLE Co (PG) filed an SEC Form 8-K — Other Events. Item 8.01 Other Events. On October 30, 2026, The Procter & Gamble Company (the “Company”) closed an underwritten public offering of $750,000,000 aggregate principal amount of 5.125% Notes due October 30, 2031, $750,000,000 aggregate principal amount of 5.300% Notes due October 30